To establish the consequences of SCD inhibition on cellular lipid composition, we determined concentrations of saturated, mono-unsaturated and poly-unsaturated FFAs in DU145 prostate cancer cells following SCD inhibition in low serum conditions (Additional file 3: Figure S3a). The gene discussed is SCD; the disease is prostate cancer.